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Abstract
Objective—Adipose derived mesenchymal stem cells (ASCs) are an exciting potential cell 
source for tissue engineering because cells can be derived from the simple excision of autologous 
fat. This study introduces a novel approach for tissue engineering cartilage from ASCs and a 
customized collagen oligomer solution, and demonstrates that the resultant cartilage can be used 
for laryngeal cartilage reconstruction in an animal model.
Methods—ASCs were isolated from F344 rats, seeded in a customized collagen matrix, and 
cultured in chondrogenic differentiation medium for 1, 2 and 4 weeks until demonstrating 
cartilage-like characteristics in vitro. Large laryngeal cartilage defects were created in the F344 rat 
model, with the engineered cartilage used to replace the cartilage defects, and the rats followed for 
1–3 months. Staining examined cellular morphology and cartilage-specific features.
Results—In vitro histological staining revealed rounded chondrocyte-appearing cells evenly 
residing throughout the customized collagen scaffold, with positive staining for cartilage-specific 
markers. The cartilage was used to successfully repair large cartilaginous defects in the rat model, 
with excellent functional results.
Conclusion—This study is the first study to demonstrate, in an animal model, that ASCs 
cultured in a unique form of collagen oligomer can create functional cartilage-like grafts which 
can be successfully used for partial laryngeal cartilage replacement.
Level of Evidence—N/A
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With recent advances in tissue engineering, a variety of cartilage engineering approaches 
have been described in the literature.1–7 Perhaps the most renowned cartilage engineering in 
the otolaryngology literature include the reports by Macchiarini et al using bone marrow-
derived mesenchymal stem cells (MSCs) on either decellularized cartilage or polyurethane 
scaffold for tracheal replacements in patients.8 The major limitation with decellularized 
cartilage and polyurethane scaffold for laryngeal cartilage engineering is that the cells coat 
the surface of the scaffold but fail to fully integrate. Since polyurethane is not a natural 
biomaterial, such as collagen, there is also increased risk of an inflammatory or foreign body 
reaction.
Ideally, engineered laryngeal cartilage would have cells evenly distributed throughout the 
scaffold, the ability to fuse with adjacent tissue (laryngeal muscle) without inducing an 
inflammatory response, and the ability to mature and stabilize in vivo. In the current study, 
we explore the use of a patented oligomeric collagen, which uniquely retains natural 
collagen intermolecular cross-links. This model supports suprafibrillar assembly to yield a 
highly interconnected D-banded collagen-fibril network that is more mechanically stable and 
resistant to proteolytic degradation compared to those formed by conventional monomeric 
collagens.9–12 The oligomer collagen scaffold is in the form of a solution that rapidly self-
assembles into a solid contiguous regeneration matrix when activated. The methodology 
allows stem cells and collagen oligomers to be suspended in solution prior to polymerization 
into a solid state, and has been shown to promote rapid vascularization in vivo.10,12 The 
physical properties can be modulated to provide the proper cell-matrix mechanotransduction 
cues for guiding ongoing cartilage development and regeneration. This approach also fosters 
in-vivo tissue integration by creating a cellular microenvironment that captures the cellular 
processes and cell-matrix signaling of embryonic cartilage development rather than mature 
cartilage. In short, this process involves the formation of a pre-cartilagenous state in which 
mesenchymal cells, interfacing with type I collagen, differentiate into chondrocytes that 
produce cartilage-specific ECM components including type II collagen and 
glycosaminoglycans.12 Since this approach mimics native cartilage development, one would 
anticipate implanted cartilage constructs to become increasingly stable in vivo, rather than 
weakening or degrading over time.
The aim of this study was to determine if a unique oligomeric collagen9–12 could be 
combined with adipose derived stem cells (ASCs) to create 3-dimensional laryngeal 
cartilage. We hypothesized that the cartilage grafts created from ASCs in collagen could be 
used to consistently repair partial laryngeal defects in a rat model. If successful, this 
approach could be readily translatable, as cartilage constructs could be derived from a 
simple fat biopsy under local anesthesia, with autologous tissue engineered cartilage derived 
within one month in culture.
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ASC Isolation and Culture
ASCs were obtained from 12-week-old male Fischer 344 rats (Envigo, Indianapolis, IN). 
Adipose tissue was collected from surrounding epididymis and cut into less than 1 mm3 
pieces. Tissue then was digested in 0.2% Collagenase IV (Sigma-Aldrich, St. Louis, MO) 
for 60 minutes at 37°C. After centrifugation at 1000 rpm for 5 minutes, the pellet was 
resuspended in ASC culture medium (Dulbecco’s Modified Eagle’s Medium, DMEM 
supplemented with 10% FBS, 1% penicillin/streptomycin/amphotericin,) and filtered 
through a 300 μm and 70 μm filter sequentially. The final cell pellet was resuspended in 
ASC culture medium and cultured at 37°C and 5% CO2. Medium was freshened twice a 
week and cells were passaged when confluent.
Chondrocyte Differentiation
4×104 ASC cells were seeded in 24 well tissue culture plates in culture medium overnight. 
Then medium was replaced with either ASC culture medium or chondrogenic medium 
(Hyclone Advance stem Chondrogenic Differentiation Medium, SH30889.02, Thermo 
Scientific). Medium was changed twice a week. After 2 weeks, morphological change was 
evaluated with microscopy. To detect type II collagen deposition, cells were fixed in 3% PFA 
for 10 minutes. After blocking with 1% BSA, cells were incubated with rabbit polyclonal to 
collagen II antibody (ab34712, Abcam Inc. Cambridge, MA) for 15 hours. The cells were 
then incubated with a secondary goat anti-rabbit antibody Alexa Fluor 488 conjugate 
(A-11034, Thermo Fisher Scientific, Carlsbad, CA) and counterstained with DAPI nuclear 
marker (4’, 6-diamidino-2-phenylindole, dihydrochloride, 62248, Thermo Fisher Scientific, 
Rockford, IL). For control chondrocyte cultures and constructs, human chondrocytes were 
attained (NHAC-kn) (Lonza Walkersville, MD,CC-250) and cultured in the supplied culture 
medium (Lonza, CC-3217) at 37°C and 5% CO2. Medium was refreshed twice a week and 
cells were passaged when confluent. For control cell differentiation, 2×104 NHAC-kn cells 
were seeded in 24 well plates in culture medium overnight, then medium was replaced with 
either supplied medium or chondrogenic medium (Hyclone Advance Stem Chondrogenic 
Differentiation Medium, SH30889.02, Thermo Scientific).
Preparation of ASC Seeded Constructs
F344 rat ASCs were grown in DMEM complete medium until they were ready to use. 5×105 
cells were mixed with 320 μl of neutralized collagen and added to a well of 96 well plate 
(Figure 1). After polymerizing, they were compressed to 0.5mm thickness scaffolds. 
Chondrogenic Differentiation Medium was added to scaffolds. Scaffolds were maintained in 
37°C, 5% CO2 incubator for up to 4 weeks. Medium was freshened twice a week.
Histological Analysis in vitro
ASCs/collagen constructs were harvested at 1, 2 and 4 weeks. Scaffolds were rinsed twice 
with PBS and fixed in 3% PFA for 1 hour, and then frozen in O.C.T Compound (4585, 
Fisher HealthCare, Houston, TX) for cryostat sectioning. Sections were cut into thickness of 
20 μm by cryotome. Standard H&E staining was used to visualize cell distribution (and 
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morphology). Safranin-o (S8884, Sigma-Aldrich, St. Louis, MO) staining was used to 
observe accumulation of sulfated proteoglycans.
Mechanical Test of Engineered Constructs
Five acellular collagen scaffolds and 5 ASC seeded collagen scaffolds were cultured in 
chondrogenic differentiation medium for 3 weeks and then submitted for compression 
testing. Compression testing was performed with samples fully hydrated, with an unconfined 
compression device set at 5.6 lb/24.9 N load cell.
In vivo study
Partial Laryngectomy Procedures—The animal study protocol was approved by 
Purdue University Animal Care and Use Committee, and institutional guidelines, in 
accordance with the National Institutes of Health guidelines, were followed for the handling 
and care of the animals. Twelve Fischer 344 male rats (Envigo, Indianapolis IN) were 
anesthetized with isoflurane via face mask (1–5%). A midline vertical skin incision 
measuring 1.0 cm was made over the larynx, with the incision carried through the skin, 
bluntly dividing the submandibular glands, and then incising and retracting the strap muscles 
inferolaterally to expose the underlying larynx. The beveled tip of an 18 gauge needle was 
used to create a window in the left thyroid cartilage, and then continued dissection used to 
resect the left lateral thyroid cartilage anteromedially (a portion of cartilage was preserved 
posteriorly over the pyriform sinus to avoid mucosal injury). The defect size was consistent 
with our prior published model,4 and the defect was large enough that repair was necessary, 
as control animals (leaving defect unrepaired) did not survive the immediate postoperative 
period. A piece of ASCs/collagen scaffold (pre-cultured in chondrogenic differentiation 
medium for 1 week) of appropriate size was implanted into the defect, the strap muscles 
were re-approximated and the skin was closed with 5–0 Vicryl suture.
Larynges were fixed with 4% paraformaldehyde in PBS for 24 hours, then changed to 30% 
sucrose in PBS solution until tissues sunk to the bottom. Tissues were frozen by cryo‐
embedding media (OCT). The larynges were cut at the axial position to sections with 
thickness of 12μm. Hematoxylin and eosin (H& E) staining was performed to show the 
structure of the scaffolds relative to the native laryngeal tissue as well as inflammation. To 
detect negatively charged sulfated proteoglycans in the implant (characteristic of cartilage), 




Within two weeks, the ASCs in ASC medium demonstrated characteristic ASC morphology 
(elongated/spindle shaped cells throughout), while the ASCs in chondrocyte differentiation 
medium (ASC-CH) became rounded and pyramidal shaped suggesting an overall change in 
outer cellular morphology (Figure 2). By three weeks, the cells were depositing collagen II 
(suggesting chondrocyte transformation) while the ASCs were not (Figure 3). These findings 
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suggested that the ASC phenotype had differentiated into that of a chondrocyte in vitro 
within a timeline of three weeks.
Histological Analysis in vitro
The ASC seeded scaffolds in ASC medium rapidly decreased in size over time, while the 
acellular scaffolds remained stable in size. However, the acellular scaffold progressively lost 
rigidity over time, becoming increasing soft and pliable to touch.. In contrast, ASC-CH 
scaffolds stayed consistent in size over time and became increasingly rigid (Figure 4, left). 
Mechanical testing supported the relative difference in stiffness between the acellular 
construct and the ASC-CH constructs (Figure 4, right). H&E staining demonstrated that, as 
the 3-dimensional ASC-CH constructs mature, the cells become increasingly round and the 
matrix demonstrates more notable lacunae-like changes consistent with maturing cartilage 
(Figure 5). Safranin-o stain, a marker for accumulated sulfated proteoglycans (characteristic 
of cartilage), became more intense over time, with dense Safranin-o positive areas noted 
throughout the ASC-CH constructs by week four (Figure 6).
In Vivo Response to ASC-CH for Cartilage Replacement
In the postsurgical period, animals steadily gained weight, and there were no problems with 
airway compromise, difficulty handling secretions, or other signs of laryngeal dysfunction. 
On gross post-mortem laryngeal examination at 1 month, the engineered graft and native 
laryngeal cartilage were in close approximation, and by 3 months the engineered graft had 
fused and healed into the native cartilage, such that the laryngeal shape was well preserved 
and it was difficult to identify the original site of the hemilaryngeal defect (Figure 7A). 
Alcian blue staining of postmortem laryngeal sections demonstrated the engineered graft to 
be weakly positive at 1 month, while at 3 months the engineered graft demonstrated blue 
stained negatively-charged sulfated proteoglycans consistent with cartilage formation 
(Figure 7B). On H&E staining, the graft maintained adequate thickness, and there was no 
evidence of any inflammatory or foreign body reaction, with adjacent myofibers healing and 
fusing within the collagen matrix of the graft (Figure 8).
Discussion
Numerous previous studies have investigated the use of chondrocyte seeded scaffolds for 
laryngotracheal airway reconstruction. For example, Kamil et al demonstrated that 
chondrocytes (derived from auricular cartilage) in polyethylene oxide/polypropylene oxide 
copolymer could be matured in vivo (in pig dorsum) and then used for laryngotracheal 
reconstruction.13 Goldstein et al used 3-dimensional printing to create a chondrocyte-coated 
poly-lactic acid (PLA) scaffold, and used it for laryngotracheal reconstruction in an animal 
(rabbit) model.14 While both these approaches are novel, if clinically translated, a generous 
cartilage biopsy (for example, a piece of septal cartilage or auricular cartilage) would be 
needed to attain chondrocytes, so it is not necessarily an advantage over the traditional 
surgical approach to harvest cartilage grafts from nasal or auricular donor sites for 
laryngotracheal reconstruction. Other approaches to engineering tracheal cartilage have 
focused on use of bone marrow derived mesenchymal stem cells for tracheal cartilage 
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reconstruction, based on either decellularized cartilage or a polymer based scaffold such as 
polyurethane.3,15
A less invasive approach would entail taking a small biopsy of adipose tissue under local 
anesthesia alone, and using these cells to create cartilage grafts for laryngotracheal 
reconstruction and/or laryngeal tissue engineering. Hashemibeni and colleagues found that 
they could repair small defects of the anterior tracheal wall with grafts which had been 
engineered from differentiated adipose-derived stem cells in an alginate-bead based 
biodegradable scaffold.16 While the grafts did develop into cartilage in vivo, the grafts were 
not well differentiated into cartilage implants in vitro, and defects were too small to 
determine if the engineered cartilage was providing adequate physiologic support. This is 
the first study to demonstrate that ASCs in a unique-developed collagen matrix can be used 
to create functional cartilage-like grafts for partial laryngeal cartilage replacement. Our 
laboratory has previously investigated other scaffold materials such as polycaprolactone 
(PCL), PLA and polyglycolic acid (PGA) with a variety of cell types, with contraction of the 
implants being a consistent problem (data unpublished). When standard collagen polymer is 
used as scaffold, cells tend to rest on the surface of the scaffold rather than being evenly 
distributed throughout the construct. The current study incorporated a unique oligomer-
based collagen as scaffold material, thereby allowing cells to evenly distribute throughout 
the scaffold, and obviating the implant contraction problems that we encountered in prior 
models. Furthermore, because the collagen is still recognized as native, there were no issues 
with inflammatory or foreign body response. Since viable cells are distributed evenly 
throughout the collagen scaffold and do not require a prefabricated mold, the implants can 
be readily customized in size and shape. Future studies will involve using the grafts in larger 
defects and larger animal models for airway laryngotracheal reconstruction, and combining 
the implants with engineered muscle and vibratory surface for hemilaryngeal replacement.
Conclusion
We demonstrate a unique, yet simple approach using a novel collagen scaffold and 
chondrocyte differentiation medium to differentiate ASCs into chondrocytes, creating 
cartilage grafts in vivo that mimic native cartilage. Future studies will be necessary to better 
define potential clinical applications of this approach to engineering laryngeal cartilage.
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Basic overview of steps to create 3-dimensional tissue engineered cartilage from adipose-
derived mesenchymal stem cells (ASCs). This novel model of using collagen oligomer 
(“Collymer”) and self-assembly reagent allows ASCs to be evenly distributed throughout the 
tissue engineered cartilage, unlike traditional models of engineering in which begins with 
cells cultured onto a scaffold in the polymerized form, thereby limiting penetration/
distribution of cells.
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(A) Phase contrast image taken at 10X magnification at 2 weeks demonstrates rounded cell 
morphology (bracket) in the adipose stem cells (ASCs) incubated in chondrocyte medium 
suggesting transformation into a chondrocyte phenotype. (B) In contrast, in the control 
medium the ASCs demonstrate more characteristic spindle, elongated morphology. (C) In 
the differentiation medium, chondrocyte change to round morphology. (D) In the control 
medium the chondrocytes demonstrate spindle and elongated morphology.
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Adipose-derived mesenchymal stem cells (ASCs) and chondrocyte in culture demonstrate 
abundant cells in both the chondrocyte medium (above) or control medium (below). DAPI 
stain demonstrates cell nuclei in blue (fluorescent microscopy, 10x). Corresponding image 
revealing collagen 2 (green) demonstrates abundant collagen 2 in the ASCs and chondrocyte 
within the chondrocyte medium, while no collagen 2 is detected from the ASCs, and less 
collagen 2 is detected from chondrocyte in the control medium.
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Three-dimensional constructs (left) with the ASC (bottom) construct representing the ASCs 
in collagen scaffold grown in ASC medium at 4 weeks; the ASC construct was initially the 
same size as the other constructs, but decreased in size over time. The Acellular (top) 
construct represents the collagen scaffold cultured without cells. The middle ASC-CH 
constructs are demonstrated at 1 week (1 ASC-CH), 2 weeks (2 ASC-CH), or 4 weeks (4 
ASC-CH) in vitro; the constructs did not change in size over time, and become subjectively 
more rigid. Compression testing (right) suggests a relative difference in stiffness of the 
constructs at 4 weeks, with the acellular construct (black line) and samples of native rat 
laryngotracheal cartilage (blue line) being displaced with compression force more than the 
ASC-CH construct (red line) when the same force is applied. Graph represents mean results 
from at least 2 samples per condition, with differences not reaching statistical significance.
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H & E stained 20 um sections of three-dimensional construct [consisting of ASCs (A-C) and 
NHAC-kn (E-G) within collagen within chondrocyte differentiation medium] at (A&E) 1 
week, (B&F) 2 weeks, and (C&G) 4 weeks in vitro [brightfield imaging at 10x]. Note that as 
the ASCs differentiate into chondrocytes, many cells become associated with lacunae-like 
changes (arrows) within the matrix; this process begins at 1 week (A) and becomes 
increasingly more defined by 4 weeks (C). Control ASCs (D) and control chondrocyte (H) in 
the same collagen matrix which have been cultured in control medium (ASC medium), with 
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cells remaining spindle-like and demonstrating no comparable cartilage-like changes in the 
matrix.
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Cartilage marker, safranin O, has been used to stain these 20 um sections of three-
dimensional construct [consisting of ASCs (A-C) and chondrocyte (E-G) within collagen 
within chondrocyte differentiation medium] at (A&E) 1 week, (B&F) 2 weeks, and (C&G) 4 
weeks in vitro [brightfield imaging at 4x for ASCs and 10x for chondrocyte]. By 4 weeks 
the implant demonstrates many areas of bright orange safranin O staining consistent with 
maturing cartilage. Control ASCs (D) and control chondrocyte (H) in the same collagen 
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matrix which have been cultured in control medium (ASC medium) and do not stain orange 
with safranin O.
Zhang et al. Page 15






















Rat larynx after explantation. Anterior view of laryngeal cartilage demonstrate normal 
overall anatomy, with just a small area of remaining white fullness externally where the left 
hemilaryngeal cartilage defect was replaced with the tissue engineered cartilage, and no 
overall distortion of the gross laryngeal anatomy.
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H & E stain of implant spanning across laryngeal cartilage defect (black arrow). Edges of 
the remaining native cartilage are demarcated with white arrows.
Zhang et al. Page 17
Laryngoscope. Author manuscript; available in PMC 2019 July 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
